Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer

Conditions: Locally Advanced Gastric Carcinoma; HER2 Negative; Efficacy; Safety Interventions: Drug: Tirolizumab+SOX/XELOX; Drug: SOX/XELOX Sponsors: Lin Chen Recruiting

https://clinicaltrials.gov/study/NCT06284746

Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials